Collet L, Eberst L, Ludovic G, Debled M, et al. Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort. Breast Cancer 2023 Jan 11. doi: 10.1007/s12282-022-01427.
PMID: 36630013